<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05080816</url>
  </required_header>
  <id_info>
    <org_study_id>MB3</org_study_id>
    <nct_id>NCT05080816</nct_id>
  </id_info>
  <brief_title>Effects of Parenteral and Enteral Nutrition on Skeletal Muscle Genomics</brief_title>
  <official_title>Effects of Parenteral and Enteral Nutrition on Skeletal Muscle Genomics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates effects related to muscle protein metabolism at provision of&#xD;
      Parenteral or enteral nutrition&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized study investigation alterations in muscle protein metabolism at provision of&#xD;
      parenteral or enteral (oral drink) nutrition. The study uses a&#xD;
      genomic/transcriptomic/proteomic approach to evaluate factors related to activation of&#xD;
      skeletal muscle protein synthesis and protein degradation. Patients scheduled for major&#xD;
      gastrointestinal surgery are included. Muscle specimens are collected during surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">October 18, 2018</completion_date>
  <primary_completion_date type="Actual">October 18, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Persons responsible for genomic/transcriptomic/proteomics analyses are blinded. All samples are coded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle protein metabolism</measure>
    <time_frame>~12-14 hours.</time_frame>
    <description>Alterations in skeletal muscle gene expression quantified by microarray</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Muscle Loss</condition>
  <arm_group>
    <arm_group_label>Parenteral nutrition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Overnight infusion of parenteral nutrition. Supplied as all-in-one-bag format. Infusion rate of 0.2 g N/kg/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enteral nutrition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral nutrition drink. 2 * 200 ml on the night before operation. 1* 200 ml on the morning of operation day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Overnight infusion of crystalloid fluid (Ringer acetate) infused at the same rate (ml/kg) as intervention PN</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Parenteral nutrition (PN)</intervention_name>
    <description>Overnight infusion of parenteral nutrition. Supplied as all-in-one-bag format. Infusion rate of 0.2 g N/kg/day.</description>
    <arm_group_label>Parenteral nutrition</arm_group_label>
    <other_name>Total parenteral nutrition (TPN)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enteral nutrition</intervention_name>
    <description>Oral nutrition drink. 2 * 200 ml on the night before operation. 1* 200 ml on the morning of operation day.</description>
    <arm_group_label>Enteral nutrition</arm_group_label>
    <other_name>nutrition drink</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Overnight infusion of crystalloid fluid (Ringer acetate) infused at the same rate (ml/kg) as intervention PN</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Major gastrointestinal surgery.&#xD;
&#xD;
          -  Assumed need of post-operative nutrition support.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Insulin dependent diabetes.&#xD;
&#xD;
          -  Steroid medication.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Britt-Marie Iresjö, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <state>Region Västra Götaland</state>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Skeletal muscle</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

